MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,03 report with the FDA on 2011-02-11 for PERFLUORON 8065900113 manufactured by Alcon - Forth Worth / Alcon Laboratories, Inc..
[18204847]
The product insert / directions for use (dfu) states a perfluoron must be completely removed from the eye and replaced with an appropriate vitreous substitute. Also the literature provides precautions to avoid inadvertent placement of perfluoron behind the retina during injection, the final fill level in the eye should always remain posterior to any large retinal breaks, additionally, the literature states if perfluoron is introduced into a large retinal break, it may slip into the subretinal space. Special care should be taken to examine for and remove any subretinal perfluoron through an existing posterior tear or through a posterior retinotomy prior to completion of surgery. No lot code was provided and no sample was returned so no further investigation could be performed at this time. Literature citation: hajime bando, toshihide ikeda, koji nakamima, takamasa minami, eriko nakatani, ryo iishi, tomohito tanaka, kosaku sawada, yoshihito oura, tatsuhiko sato and kazuyuki emi: analysis of cases with perfluorocarbon liquid remaining in eyes. Abstracts of the 34th annual meeting of the japanese society of ophthalmology. (b)(4).
Patient Sequence No: 1, Text Type: N, H10
[18227657]
Literature article reports: a (b)(6), male, underwent surgery for repair of a retinal detachment. A vitrectomy was performed and perfluoro-n-octane (pfo) was used. Ten days later the patient had an additional surgery to repair a retinal re-detachment. No pfo was used. At the patient's two month exam, the surgeon noted pfo residues, (eight spots) under the retina, outside of fovea in macula. The ten month post operative exam, the surgeon noted visual field loss, but the surgeon thought it might be caused by pvr" (proliferative vitreoretinopathy). The position of pfo residue was not corresponding to the visual field loss. The patient is being observed. This is the second of four medical device reports being reported for this literature report.
Patient Sequence No: 1, Text Type: D, B5
| Report Number | 1610287-2011-00013 |
| MDR Report Key | 1993671 |
| Report Source | 01,03 |
| Date Received | 2011-02-11 |
| Date of Report | 2011-01-12 |
| Date of Event | 2009-11-20 |
| Date Mfgr Received | 2011-01-12 |
| Date Added to Maude | 2011-02-18 |
| Event Key | 0 |
| Report Source Code | Manufacturer report |
| Manufacturer Link | Y |
| Number of Patients in Event | 0 |
| Adverse Event Flag | 3 |
| Product Problem Flag | 3 |
| Reprocessed and Reused Flag | 3 |
| Health Professional | 3 |
| Initial Report to FDA | 3 |
| Report to FDA | 0 |
| Event Location | 0 |
| Manufacturer Contact | CHARLES DOLBEE |
| Manufacturer Street | 6201 SOUTH FREEWAY R7-18 |
| Manufacturer City | FORT WORTH TX 76134 |
| Manufacturer Country | US |
| Manufacturer Postal | 76134 |
| Manufacturer Phone | 8175518317 |
| Manufacturer G1 | ALCON - FORT WORTH / ALCON LABORATORIES, INC. |
| Manufacturer Street | 6201 SOUTH FREEWAY |
| Manufacturer City | FORT WORTH TX 76134 |
| Manufacturer Country | US |
| Manufacturer Postal Code | 76134 |
| Single Use | 3 |
| Previous Use Code | 3 |
| Removal Correction Number | NA |
| Event Type | 3 |
| Type of Report | 3 |
| Brand Name | PERFLUORON |
| Generic Name | FLUID, INTRAOCULAR |
| Product Code | LWL |
| Date Received | 2011-02-11 |
| Model Number | 8065900113 |
| Catalog Number | 8065900113 |
| Lot Number | UNK |
| ID Number | NA |
| Operator | HEALTH PROFESSIONAL |
| Device Availability | N |
| Device Age | DA |
| Device Eval'ed by Mfgr | R |
| Device Sequence No | 1 |
| Device Event Key | 0 |
| Manufacturer | ALCON - FORTH WORTH / ALCON LABORATORIES, INC. |
| Manufacturer Address | 6201 SOUTH FREEWAY FORT WORTH TX 76134 US 76134 |
| Patient Number | Treatment | Outcome | Date |
|---|---|---|---|
| 1 | 0 | 1. Other | 2011-02-11 |